# PDE6G

## Overview
PDE6G is a gene that encodes the gamma subunit of the rod photoreceptor cGMP phosphodiesterase, a key enzyme in the phototransduction pathway. This enzyme is crucial for the conversion of light signals into electrical signals in the retina, facilitating vision. The protein phosphodiesterase 6G, categorized as a regulatory subunit, plays a significant role in modulating the activity of the PDE6 complex by inhibiting its catalytic subunits, PDE6A and PDE6B, in the absence of light. Upon light activation, PDE6G interacts with the G-protein transducin, leading to the hydrolysis of cGMP and subsequent closure of cyclic nucleotide-gated channels, which is essential for visual signal transmission. Beyond its role in the retina, PDE6G is also involved in cellular signaling pathways in other tissues, such as the lung and kidney, indicating its broader physiological significance (ZengElmore2014Molecular; Dong2013Expression).

## Structure
The PDE6G gene encodes the gamma subunit of rod photoreceptor cGMP phosphodiesterase, which plays a crucial role in the phototransduction pathway. The primary structure of PDE6G consists of a specific sequence of amino acids that form the basis for its function. The secondary structure includes alpha helices and beta sheets, which contribute to the protein's stability and function (Barren2009Structural).

In terms of tertiary structure, PDE6G folds into a three-dimensional shape that allows it to interact with other subunits of the phosphodiesterase complex. This folding is essential for its regulatory role in inhibiting the catalytic activity of the PDE6αβ heterodimer (Gulati2019CryoEM). The quaternary structure involves the interaction of PDE6G with the PDE6α and PDE6β subunits, forming a complex that is crucial for visual phototransduction (ZengElmore2014Molecular).

PDE6G contains specific domains that are vital for its function, including regions that interact with the GAF domains of the catalytic subunits, which are involved in cGMP binding and regulation (ZengElmore2014Molecular). The protein may undergo post-translational modifications, such as phosphorylation, which can affect its activity and regulation. Splice variant isoforms of PDE6G may exist, potentially influencing its functional properties.

## Function
PDE6G encodes the gamma subunit of the rod photoreceptor cGMP phosphodiesterase, a critical enzyme in the phototransduction pathway. This enzyme is essential for converting light signals into electrical signals in the retina, a process vital for vision. In healthy human cells, PDE6G is active in the photoreceptor outer segments, where it regulates the levels of cyclic guanosine monophosphate (cGMP) (sothilingam2016dissection). 

Upon activation by light, PDE6G, as part of the PDE6 complex, catalyzes the hydrolysis of cGMP. This reduction in cGMP levels leads to the closure of cyclic nucleotide-gated (CNG) channels, resulting in the hyperpolarization of the photoreceptor cell membrane. This change in membrane potential is crucial for the transmission of visual signals to the brain (sothilingam2016dissection). 

PDE6G also plays a role in other tissues, such as the lung and kidney, where it is involved in the activation of the MAP kinase pathway by epidermal growth factor signaling (Dong2013Expression). This suggests that PDE6G may have broader roles in cellular signaling beyond its function in the retina.

## Clinical Significance
Mutations and alterations in the PDE6G gene are associated with several clinical conditions. A notable mutation, c.187+1G>T, in PDE6G is linked to autosomal-recessive early-onset retinitis pigmentosa (RP). This mutation affects the splicing of PDE6G transcripts, leading to an abnormal protein product and resulting in severe retinal degeneration characterized by symptoms such as reduced electroretinograms and bone spicule-type pigment deposits (Dvir2010AutosomalRecessive). Another study identified a complex heterozygous mutation in PDE6G, involving a frameshift mutation and a segment deletion, which also leads to autosomal recessive retinitis pigmentosa, specifically retinitis pigmentosa type 57 (Liu2024Analysis).

Alterations in PDE6G expression levels are implicated in myelofibrosis-related anemia. PDE6G inhibits the expression of CD71 in erythroid progenitor cells through the PDE6G/BHLHE40/miR-144-3p/CD71 pathway, leading to impaired red cell production and anemia. Higher PDE6G expression is observed in patients with myelofibrosis-related anemia compared to those without anemia, suggesting its role in the disease's pathogenesis (Wu2024PDE6G).

Additionally, a genetic variant within the NPLOC4-TSPAN10-PDE6G gene cluster has been associated with an increased risk of strabismus, indicating a potential genetic component in the development of this condition (Plotnikov2019A).

## Interactions
PDE6G, the γ-subunit of the rod photoreceptor cGMP phosphodiesterase, plays a critical role in visual transduction by interacting with several proteins. It forms a nonactivated holoenzyme complex with the catalytic dimer of PDE6, composed of PDE6A and PDE6B subunits, by binding to two distinct high-affinity sites on the dimer (Mou2001The). The N-terminal region of PDE6G binds with higher affinity than the C-terminal region, which is responsible for inhibiting catalysis (Mou2001The).

PDE6G also interacts with the G-protein transducin. Upon light activation, transducin binds to PDE6G, relieving its inhibitory effect on PDE6 and allowing the enzyme to hydrolyze cGMP, a crucial step in the phototransduction cascade (Zhang2012Functional). The glycine-rich region of PDE6G is essential for its interaction with the transducin α-subunit, facilitating the activation of PDE6 (Zhang2012Functional).

Additionally, PDE6G interacts with the regulator of G-protein signaling 9-1 (RGS9-1), forming a complex that accelerates the GTPase activity of activated transducin, which is important for the deactivation of PDE6 and recovery of the dark-adapted state (Zhang2012Functional). These interactions highlight the multifaceted role of PDE6G in regulating visual signal transduction.


## References


[1. (Dvir2010AutosomalRecessive) Liron Dvir, Gassoub Srour, Rasmi Abu-Ras, Benjamin Miller, Stavit A. Shalev, and Tamar Ben-Yosef. Autosomal-recessive early-onset retinitis pigmentosa caused by a mutation in pde6g, the gene encoding the gamma subunit of rod cgmp phosphodiesterase. The American Journal of Human Genetics, 87(2):258–264, August 2010. URL: http://dx.doi.org/10.1016/j.ajhg.2010.06.016, doi:10.1016/j.ajhg.2010.06.016. This article has 68 citations.](https://doi.org/10.1016/j.ajhg.2010.06.016)

[2. (Plotnikov2019A) Denis Plotnikov, Rupal L. Shah, Jamille N. Rodrigues, Phillippa M. Cumberland, Jugnoo S. Rahi, Pirro G. Hysi, Denize Atan, Cathy Williams, and Jeremy A. Guggenheim. A commonly occurring genetic variant within the nploc4–tspan10–pde6g gene cluster is associated with the risk of strabismus. Human Genetics, 138(7):723–737, May 2019. URL: http://dx.doi.org/10.1007/s00439-019-02022-8, doi:10.1007/s00439-019-02022-8. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00439-019-02022-8)

3. (sothilingam2016dissection) Vithiyanjali Sothilingam. Dissection of visual signalling based on functionally specific rod photoreceptor mutants. PhD thesis, Universität Tübingen, 2016. This article has 1 citations.

4. (Wu2024PDE6G) PDE6G inhibits the expression of CD71 in erythroid progenitor cells through the PDE6G/BHLHE40/miR144-3p/CD71 pathway, leading to red cell production obstacles and ultimately causing anemia in myelofibrosis. This article has 0 citations.

[5. (Mou2001The) Hongmei Mou and Rick H. Cote. The catalytic and gaf domains of the rod cgmp phosphodiesterase (pde6) heterodimer are regulated by distinct regions of its inhibitory γ subunit. Journal of Biological Chemistry, 276(29):27527–27534, July 2001. URL: http://dx.doi.org/10.1074/jbc.m103316200, doi:10.1074/jbc.m103316200. This article has 74 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m103316200)

[6. (Dong2013Expression) Hongli Dong, Kevin P Claffey, Stefan Brocke, and Paul M Epstein. Expression of phosphodiesterase 6 (pde6) in human breast cancer cells. SpringerPlus, December 2013. URL: http://dx.doi.org/10.1186/2193-1801-2-680, doi:10.1186/2193-1801-2-680. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/2193-1801-2-680)

[7. (Zhang2012Functional) Xiu-Jun Zhang, Xiong-Zhuo Gao, Wei Yao, and Rick H. Cote. Functional mapping of interacting regions of the photoreceptor phosphodiesterase (pde6) γ-subunit with pde6 catalytic dimer, transducin, and regulator of g-protein signaling9–1 (rgs9–1). Journal of Biological Chemistry, 287(31):26312–26320, July 2012. URL: http://dx.doi.org/10.1074/jbc.m112.377333, doi:10.1074/jbc.m112.377333. This article has 16 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m112.377333)

[8. (Gulati2019CryoEM) Sahil Gulati, Krzysztof Palczewski, Andreas Engel, Henning Stahlberg, and Lubomir Kovacik. Cryo-em structure of phosphodiesterase 6 reveals insights into the allosteric regulation of type i phosphodiesterases. Science Advances, February 2019. URL: http://dx.doi.org/10.1126/sciadv.aav4322, doi:10.1126/sciadv.aav4322. This article has 34 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/sciadv.aav4322)

[9. (ZengElmore2014Molecular) Xiaohui Zeng-Elmore, Xiong-Zhuo Gao, Riccardo Pellarin, Dina Schneidman-Duhovny, Xiu-Jun Zhang, Katie A. Kozacka, Yang Tang, Andrej Sali, Robert J. Chalkley, Rick H. Cote, and Feixia Chu. Molecular architecture of photoreceptor phosphodiesterase elucidated by chemical cross-linking and integrative modeling. Journal of Molecular Biology, 426(22):3713–3728, November 2014. URL: http://dx.doi.org/10.1016/j.jmb.2014.07.033, doi:10.1016/j.jmb.2014.07.033. This article has 36 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jmb.2014.07.033)

[10. (Barren2009Structural) Brandy Barren, Lokesh Gakhar, Hakim Muradov, Kimberly K Boyd, S Ramaswamy, and Nikolai O Artemyev. Structural basis of phosphodiesterase 6 inhibition by the c-terminal region of the γ-subunit. The EMBO Journal, 28(22):3613–3622, October 2009. URL: http://dx.doi.org/10.1038/emboj.2009.284, doi:10.1038/emboj.2009.284. This article has 52 citations.](https://doi.org/10.1038/emboj.2009.284)

[11. (Liu2024Analysis) Xiaona Liu, Peiyan Shi, and Jinling Ge. Analysis of pde6g mutations in a patient with retinitis pigmentosa. BMC Ophthalmology, August 2024. URL: http://dx.doi.org/10.1186/s12886-024-03623-2, doi:10.1186/s12886-024-03623-2. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12886-024-03623-2)